190 related articles for article (PubMed ID: 28087741)
41. Checkpoint kinase 2 (Chk2) supports sensitivity to platinum-based treatment in high grade serous ovarian cancer.
Alkema NG; Tomar T; van der Zee AG; Everts M; Meersma GJ; Hollema H; de Jong S; van Vugt MA; Wisman GB
Gynecol Oncol; 2014 Jun; 133(3):591-8. PubMed ID: 24657486
[TBL] [Abstract][Full Text] [Related]
42. The Effect of MicroRNA-124 Overexpression on Anti-Tumor Drug Sensitivity.
Chen SM; Chou WC; Hu LY; Hsiung CN; Chu HW; Huang YL; Hsu HM; Yu JC; Shen CY
PLoS One; 2015; 10(6):e0128472. PubMed ID: 26115122
[TBL] [Abstract][Full Text] [Related]
43. TKT-PARP1 axis induces radioresistance by promoting DNA double-strand break repair in hepatocellular carcinoma.
Geng L; Zhu M; Luo D; Chen H; Li B; Lao Y; An H; Wu Y; Li Y; Xia A; Shi Y; Tong Z; Lu S; Xu D; Wang X; Zhang W; Sun B; Xu Z
Oncogene; 2024 Feb; 43(9):682-692. PubMed ID: 38216672
[TBL] [Abstract][Full Text] [Related]
44. The role of DNA damage repair and Chk2 protein in hyper-radiosensitivity of lung adenocarcinoma A549 cells.
Wu H; Chen Q; Zhang Y; Wu G; Meng R; Cheng J
J Huazhong Univ Sci Technolog Med Sci; 2012 Oct; 32(5):750-754. PubMed ID: 23073808
[TBL] [Abstract][Full Text] [Related]
45. c-MYC suppresses BIN1 to release poly(ADP-ribose) polymerase 1: a mechanism by which cancer cells acquire cisplatin resistance.
Pyndiah S; Tanida S; Ahmed KM; Cassimere EK; Choe C; Sakamuro D
Sci Signal; 2011 Mar; 4(166):ra19. PubMed ID: 21447800
[TBL] [Abstract][Full Text] [Related]
46. Regulation of repair pathway choice at two-ended DNA double-strand breaks.
Shibata A
Mutat Res; 2017 Oct; 803-805():51-55. PubMed ID: 28781144
[TBL] [Abstract][Full Text] [Related]
47. Sensitizing thermochemotherapy with a PARP1-inhibitor.
Oei AL; Vriend LE; van Leeuwen CM; Rodermond HM; Ten Cate R; Westermann AM; Stalpers LJ; Crezee J; Kanaar R; Kok HP; Krawczyk PM; Franken NA
Oncotarget; 2017 Mar; 8(10):16303-16312. PubMed ID: 27557507
[TBL] [Abstract][Full Text] [Related]
48. DNA repair kinetics in SCID mice Sertoli cells and DNA-PKcs-deficient mouse embryonic fibroblasts.
Ahmed EA; Vélaz E; Rosemann M; Gilbertz KP; Scherthan H
Chromosoma; 2017 Mar; 126(2):287-298. PubMed ID: 27136939
[TBL] [Abstract][Full Text] [Related]
49. New opportunities in chemosensitization and radiosensitization: modulating the DNA-damage response.
Luo Y; Leverson JD
Expert Rev Anticancer Ther; 2005 Apr; 5(2):333-42. PubMed ID: 15877529
[TBL] [Abstract][Full Text] [Related]
50. DNA-PKcs: A promising therapeutic target in human hepatocellular carcinoma?
Pascale RM; Joseph C; Latte G; Evert M; Feo F; Calvisi DF
DNA Repair (Amst); 2016 Nov; 47():12-20. PubMed ID: 27789167
[TBL] [Abstract][Full Text] [Related]
51. Wig-1 regulates cell cycle arrest and cell death through the p53 targets FAS and 14-3-3σ.
Bersani C; Xu LD; Vilborg A; Lui WO; Wiman KG
Oncogene; 2014 Aug; 33(35):4407-17. PubMed ID: 24469038
[TBL] [Abstract][Full Text] [Related]
52. Aurora-A controls cancer cell radio- and chemoresistance via ATM/Chk2-mediated DNA repair networks.
Sun H; Wang Y; Wang Z; Meng J; Qi Z; Yang G
Biochim Biophys Acta; 2014 May; 1843(5):934-44. PubMed ID: 24480460
[TBL] [Abstract][Full Text] [Related]
53. Hyper-active non-homologous end joining selects for synthetic lethality resistant and pathological Fanconi anemia hematopoietic stem and progenitor cells.
Du W; Amarachintha S; Wilson AF; Pang Q
Sci Rep; 2016 Feb; 6():22167. PubMed ID: 26916217
[TBL] [Abstract][Full Text] [Related]
54. BRN2 suppresses apoptosis, reprograms DNA damage repair, and is associated with a high somatic mutation burden in melanoma.
Herbert K; Binet R; Lambert JP; Louphrasitthiphol P; Kalkavan H; Sesma-Sanz L; Robles-Espinoza CD; Sarkar S; Suer E; Andrews S; Chauhan J; Roberts ND; Middleton MR; Gingras AC; Masson JY; Larue L; Falletta P; Goding CR
Genes Dev; 2019 Mar; 33(5-6):310-332. PubMed ID: 30804224
[TBL] [Abstract][Full Text] [Related]
55. The complexity of DNA double strand break is a crucial factor for activating ATR signaling pathway for G2/M checkpoint regulation regardless of ATM function.
Xue L; Furusawa Y; Okayasu R; Miura M; Cui X; Liu C; Hirayama R; Matsumoto Y; Yajima H; Yu D
DNA Repair (Amst); 2015 Jan; 25():72-83. PubMed ID: 25497328
[TBL] [Abstract][Full Text] [Related]
56. Phosphatidylinositol 3-kinase/Akt signaling as a key mediator of tumor cell responsiveness to radiation.
Toulany M; Rodemann HP
Semin Cancer Biol; 2015 Dec; 35():180-90. PubMed ID: 26192967
[TBL] [Abstract][Full Text] [Related]
57. Spindle Checkpoint Factors Bub1 and Bub2 Promote DNA Double-Strand Break Repair by Nonhomologous End Joining.
Jessulat M; Malty RH; Nguyen-Tran DH; Deineko V; Aoki H; Vlasblom J; Omidi K; Jin K; Minic Z; Hooshyar M; Burnside D; Samanfar B; Phanse S; Freywald T; Prasad B; Zhang Z; Vizeacoumar F; Krogan NJ; Freywald A; Golshani A; Babu M
Mol Cell Biol; 2015 Jul; 35(14):2448-63. PubMed ID: 25963654
[TBL] [Abstract][Full Text] [Related]
58. Inhibition of homologous recombination by hyperthermia shunts early double strand break repair to non-homologous end-joining.
Bergs JW; Krawczyk PM; Borovski T; ten Cate R; Rodermond HM; Stap J; Medema JP; Haveman J; Essers J; van Bree C; Stalpers LJ; Kanaar R; Aten JA; Franken NA
DNA Repair (Amst); 2013 Jan; 12(1):38-45. PubMed ID: 23237939
[TBL] [Abstract][Full Text] [Related]
59. Inhibition of PARP1 activity enhances chemotherapeutic efficiency in cisplatin-resistant gastric cancer cells.
Wang Q; Xiong J; Qiu D; Zhao X; Yan D; Xu W; Wang Z; Chen Q; Panday S; Li A; Wang S; Zhou J
Int J Biochem Cell Biol; 2017 Nov; 92():164-172. PubMed ID: 28827033
[TBL] [Abstract][Full Text] [Related]
60. Curcumin suppresses multiple DNA damage response pathways and has potency as a sensitizer to PARP inhibitor.
Ogiwara H; Ui A; Shiotani B; Zou L; Yasui A; Kohno T
Carcinogenesis; 2013 Nov; 34(11):2486-97. PubMed ID: 23825154
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
